| 16. | INVESTMENT
IN A JOINT VENTURE |
| |
|
As
at December 31, |
|
| |
|
2024 |
|
|
2025 |
|
|
2025 |
|
| |
|
RMB |
|
|
RMB |
|
|
US$ |
|
| Share of
net assets |
|
|
32,717 |
|
|
|
33,030 |
|
|
|
4,723 |
|
Particulars
of the Group’s principal joint venture are as follows:
| Name | | Place of registration and business | | Registered share capital | | | Percentage of ownership interest | | | Principal activities | | | | | | | RMB | | | | | | | | | | | | | | | | | | | | | Suzhou Ascentage Harvest Venture Capital LLP* (“Ascentage Harvest”) | | PRC | | | 360,000 | | | | 33.42 | %** | | Investment in Biotechnology companies |
The
above investment is indirectly held by the Company.
| * | The English name of the company registered in the PRC represents the best efforts made by the management of the Company in directly translating the Chinese name of this Company as no English name has been registered. |
| ** | The Group holds two of three representatives in the committee that directs the relevant activities of Ascentage Harvest. As a result, the Group has significant influence over the financial and operating policy decisions of Ascentage Harvest. |
The
following table illustrates the summarized financial information of the Group’s joint venture:
| | |
As
at December 31, | |
| | |
2024 | | |
2025 | | |
2025 | |
| | |
RMB | | |
RMB | | |
US$ | |
Share
of the joint venture’s (loss)/gain for the year | |
| (281 | ) | |
| 314 | | |
| 45 | |
Share
of the joint venture’s total comprehensive (loss)/gain for the year | |
| (281 | ) | |
| 314 | | |
| 45 | |
| Aggregate carrying amount
of the Group’s investment in the joint venture | |
| 32,717 | | |
| 33,030 | | |
| 4,723 | |
|